Speaker illustration

Doctor Steve Hughes

Ionis Pharmaceuticals Inc, Carlsbad (United States of America)

Inotersen improved quality of life, polyneuropathy and cardiomyopathy in a diverse group of patients with hereditary transthyretin amyloidosis in the phase 3 study NEURO-TTR

Event: ESC Congress 2018

Topic: Infiltrative Myocardial Disease

Session: Cardiomyopathies: various aspects


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb